Astrana Health, Inc.
ASTH
$29.19
-$0.64-2.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.08% | -43.92% | -28.93% | 39.93% | 49.52% |
| Total Depreciation and Amortization | 34.02% | 59.98% | 57.35% | 46.09% | 25.26% |
| Total Amortization of Deferred Charges | 76.26% | 60.76% | 72.29% | 82.05% | 60.17% |
| Total Other Non-Cash Items | 163.61% | 276.72% | 254.93% | -63.77% | 0.75% |
| Change in Net Operating Assets | 151.70% | -75.60% | -171.99% | -142.71% | -56,674.39% |
| Cash from Operations | 104.42% | -5.47% | -23.49% | -38.41% | -22.67% |
| Capital Expenditure | 35.16% | 23.60% | 71.85% | 43.84% | 33.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 73.92% | -67.27% | -2,146.01% | -661.30% | -701.95% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.64% | 66.08% | -25.00% | -1,199.49% | -373.12% |
| Cash from Investing | 77.24% | -1.00% | -193.63% | -316.92% | -1,298.45% |
| Total Debt Issued | -8.73% | 20.61% | -39.59% | 9,420.12% | 10,965.03% |
| Total Debt Repaid | -107.52% | -116.57% | 86.68% | -17,291.91% | -4,633.24% |
| Issuance of Common Stock | 387.87% | 387.87% | -32.59% | -89.66% | -96.82% |
| Repurchase of Common Stock | -73.92% | -1,377.95% | 45.06% | 46.38% | 56.35% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 89.97% | 91.23% | 99.85% | -1,554.78% | -343.11% |
| Other Financing Activities | -297.60% | -382.31% | 4.00% | -1,778.41% | -186.58% |
| Cash from Financing | -143.17% | -113.16% | 3,850.48% | 6,112.81% | 2,055.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.58% | -225.40% | -182.47% | -17.63% | -47.22% |